etafilcon A (A)
DeviceDaily wear contact lens
Other names: printed etafilcon A Lens with PVP (A)
NCT Number: NCT01180777
The purpose of this study is to evaluate the lens fit (mechanical and cosmetic lens fit) of the printed etafilcon A with polyvinylpyrrolidone (PVP).
Looking for future studies?
Notify Me18 year–40 year
Female
Interventional
Not applicable
Cupertino, California, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Daily wear contact lens
Other names: printed etafilcon A Lens with PVP (A)
Daily wear contact lens
Other names: printed etafilcon A Lens PVP (B)
Daily wear contact lens
Other names: printed etafilcon A Lens PVP (C)
Time frame: 10-15 minutes post lens fit
Lens fit acceptance (whether acceptable or unacceptable) was assessed by the Investigator at dispensing.
Time frame: 10-15 minutes post lens fit
Binocular Snellen VA was assessed at dispensing by Investigator using a Snellen vision chart. Subjects were analyzed based on their performance on a Snellen Vision chart exam in the study lenses in an effort to measure how well the lenses perform for vision correction.
Time frame: After 6-9 days of lens wear
Corneal staining type was graded in a 5-point scale over the 5 corneal regions by Investigator using a slit lamp; 0=none, 1=trace, 2=mild, 3=moderate, and 4=severe. Maximum grade of corneal staining type over the 5 corneal regions was categorized either absence or presence of corneal staining for the analysis.
Johnson & Johnson Vision Care, Inc.
Industry
Dispensing Evaluation of Printed Etafilcon A With Polyvinylpyrrolidone (PVP) Contact Lenses
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03334253
Eye Diseases, Myopia
Birmingham, Alabama, United States
View Trial DetailsNCT07087665
Eye Diseases, Myopia
Saint Louis Park, Minnesota, United States
View Trial DetailsNCT06700460
Eye Diseases, Myopia
Omaha, Nebraska, United States
View Trial DetailsNCT00320593
Eye Diseases, Myopia
Birmingham, Alabama, United States
View Trial Details